Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,523 | 10 | 81.8% |
| Travel and Lodging | $2,103 | 5 | 13.7% |
| Food and Beverage | $636.21 | 9 | 4.2% |
| Education | $42.00 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $7,548 | 12 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $5,550 | 7 | $0 (2023) |
| Advanced Respiratory, Inc | $1,797 | 3 | $0 (2018) |
| HILL-ROM COMPANY, INC | $290.82 | 1 | $0 (2017) |
| Genentech USA, Inc. | $117.56 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $4,102 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($4,102) |
| 2022 | $1,420 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($1,420) |
| 2018 | $9,345 | 15 | AstraZeneca Pharmaceuticals LP ($7,548) |
| 2017 | $435.56 | 4 | HILL-ROM COMPANY, INC ($290.82) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/04/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,879.69 | General |
| Category: RESPIRATORY | ||||||
| 01/08/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $2,222.67 | General |
| Category: RESPIRATORY | ||||||
| 05/16/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $556.10 | General |
| Category: RESPIRATORY | ||||||
| 05/16/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $427.77 | General |
| Category: RESPIRATORY | ||||||
| 01/13/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $247.75 | General |
| Category: RESPIRATORY | ||||||
| 01/13/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $188.74 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2018 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,550.00 | General |
| Category: Respiratory | ||||||
| 10/10/2018 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: Respiratory | ||||||
| 09/06/2018 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,550.00 | General |
| Category: Respiratory | ||||||
| 08/28/2018 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $124.73 | General |
| Category: Respiratory | ||||||
| 08/28/2018 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Travel and Lodging | In-kind items and services | $14.72 | General |
| Category: Respiratory | ||||||
| 08/09/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Respiratory | ||||||
| 08/02/2018 | Advanced Respiratory, Inc | The MetaNeb System (Device), The Vest System Model 205 Acute Care | Travel and Lodging | In-kind items and services | $1,028.38 | General |
| Category: Airway Clearance Device | ||||||
| 08/02/2018 | Advanced Respiratory, Inc | The MetaNeb System (Device), The Vest System Model 205 Acute Care | Travel and Lodging | In-kind items and services | $160.00 | General |
| Category: Airway Clearance Device | ||||||
| 07/31/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,350.00 | General |
| Category: Respiratory | ||||||
| 07/25/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $106.39 | General |
| Category: Respiratory | ||||||
| 07/22/2018 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,550.00 | General |
| Category: Respiratory | ||||||
| 07/12/2018 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $3.53 | General |
| 07/11/2018 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $116.84 | General |
| Category: Respiratory | ||||||
| 03/12/2018 | Advanced Respiratory, Inc | The MetaNeb System (Device) | Travel and Lodging | In-kind items and services | $608.64 | General |
| Category: Airway Clearance Device | ||||||
| 03/07/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug), SYMBICORT | Education | In-kind items and services | $42.00 | General |
| Category: Respiratory | ||||||
| 10/30/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2017 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Immunology | ||||||
| 10/29/2017 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $97.35 | General |
| Category: Immunology | ||||||
| 09/26/2017 | HILL-ROM COMPANY, INC | The MetaNeb System (Device) | Travel and Lodging | In-kind items and services | $290.82 | General |
| Category: Airway Clearance Device | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 101 | 126 | $49,378 | $12,317 |
| 2022 | 3 | 150 | 179 | $62,495 | $17,821 |
| 2021 | 4 | 171 | 212 | $60,845 | $17,990 |
| 2020 | 5 | 234 | 283 | $73,735 | $17,646 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 67 | 84 | $29,094 | $7,092 | 24.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 34 | 42 | $20,284 | $5,225 | 25.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 53 | 65 | $28,680 | $8,229 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 78 | 92 | $29,190 | $7,674 | 26.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 19 | 22 | $4,625 | $1,918 | 41.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 82 | 99 | $30,335 | $8,256 | 27.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 37 | 56 | $11,312 | $4,208 | 37.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 28 | 33 | $14,051 | $4,166 | 29.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 24 | 24 | $5,147 | $1,360 | 26.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 91 | 121 | $36,140 | $7,688 | 21.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 36 | 39 | $16,211 | $3,656 | 22.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 32 | 37 | $7,215 | $2,627 | 36.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 35 | 44 | $5,440 | $1,998 | 36.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 40 | 42 | $8,729 | $1,677 | 19.2% |
About Dr. Timothy Liesching, M.D
Dr. Timothy Liesching, M.D is a Critical Care Medicine healthcare provider based in Burlington, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730136433.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Liesching, M.D has received a total of $15,303 in payments from pharmaceutical and medical device companies, with $4,102 received in 2023. These payments were reported across 25 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($12,523).
As a Medicare-enrolled provider, Liesching has provided services to 656 Medicare beneficiaries, totaling 800 services with total Medicare billing of $65,774. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Burlington, MA
- Active Since 05/28/2006
- Last Updated 02/21/2024
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1730136433
Products in Payments
- OFEV (Drug) $5,550
- BEVESPI AEROSPHERE (Drug) $5,031
- SYMBICORT (Drug) $2,456
- The MetaNeb System (Device) $2,088
- Esbriet (Biological) $117.56
- FASENRA (Drug) $57.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Burlington
Ioana Preston, Md, MD
Critical Care Medicine — Payments: $495,322
Adam Smith, Md, MD
Critical Care Medicine — Payments: $350,856
Dr. David Kaminsky, Md, MD
Critical Care Medicine — Payments: $29,888
Dr. Cyrus Kholdani, Md, MD
Critical Care Medicine — Payments: $16,195
Dr. Dirk Varelmann, M.d, M.D
Critical Care Medicine — Payments: $5,723
Aasim Mohammed, M.d, M.D
Critical Care Medicine — Payments: $3,053